Exane Derivatives’s RTX Corp RTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$2.69K Hold
28
﹤0.01% 419
2022
Q1
$2.77K Hold
28
﹤0.01% 732
2021
Q4
$2.41K Sell
28
-629
-96% -$54.8K ﹤0.01% 651
2021
Q3
$56.5K Hold
657
0.01% 606
2021
Q2
$56.1K Sell
657
-161
-20% -$13.5K 0.01% 638
2021
Q1
$63.2K Buy
818
+295
+56% +$21.5K 0.02% 496
2020
Q4
$37.4K Buy
523
+495
+1,768% +$32.5K 0.01% 479
2020
Q3
$1.61K Hold
28
﹤0.01% 582
2020
Q2
$1.73K Sell
28
-18,106
-100% -$1.13M ﹤0.01% 513
2020
Q1
$1.08M Buy
18,134
+2,427
+15% +$205K 0.3% 78
2019
Q4
$1.5M Buy
15,707
+1,948
+14% +$177K 0.28% 92
2019
Q3
$1.18M Buy
13,759
+628
+5% +$52.1K 0.21% 90
2019
Q2
$1.08M Buy
13,131
+672
+5% +$56.2K 0.19% 103
2019
Q1
$1.01M Buy
12,459
+12,038
+2,859% +$915K 0.2% 115
2018
Q4
$28.2K Hold
421
0.01% 419
2018
Q3
$37.1K Sell
421
-3,113
-88% -$261K 0.01% 383
2018
Q2
$280K Buy
3,534
+3,532
+176,600% +$277K 0.05% 227
2018
Q1
$125 Hold
2
﹤0.01% 543
2017
Q4
$128 Sell
2
-1
-33% -$76 ﹤0.01% 535
2017
Q3
$232 Sell
3
-1,837
-100% -$136K ﹤0.01% 486
2017
Q2
$141K Buy
+1,840
New +$138K 0.03% 232

Other funds holding RTX

Exane Derivatives's RTX Position: Q2 2022 in Review

Exane Derivatives held its RTX Corp (RTX) position steady in Q2 2022 at 28 shares worth $2.69K. The position accounts for ﹤0.01% of the portfolio, ranked #419.

Exane Derivatives first reported a position in RTX in Q2 2017 and has held it in 21 quarters since. The position peaked at $1.5M in Q4 2019. 2,289 funds tracked by Wall St. Rank hold RTX as of Q2 2022.

  • Exane Derivatives held 28 shares of RTX Corp worth $2.69K as of Q2 2022.
  • Exane Derivatives left its RTX Corp share count unchanged in Q2 2022.
  • RTX Corp made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #419 holding.
  • Exane Derivatives first reported a position in RTX Corp in Q2 2017 and has held it in 21 quarters since.
  • Exane Derivatives's RTX Corp position peaked at $1.5M in Q4 2019.
  • 2,289 funds tracked by Wall St. Rank held RTX Corp as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.